Intestinal spirochetosis
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Intestinal spirochetosis | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Diarrhea, abdominal pain, bloating, rectal bleeding |
| Complications | Malabsorption, anemia |
| Onset | Variable |
| Duration | Chronic |
| Types | N/A |
| Causes | Brachyspira aalborgi, Brachyspira pilosicoli |
| Risks | Immunocompromised state, HIV/AIDS, homosexual men |
| Diagnosis | Colonoscopy, biopsy, histopathology |
| Differential diagnosis | Inflammatory bowel disease, irritable bowel syndrome, infectious colitis |
| Prevention | N/A |
| Treatment | Antibiotics such as metronidazole, tetracycline |
| Medication | N/A |
| Prognosis | Generally good with treatment |
| Frequency | Rare |
| Deaths | N/A |
Intestinal Spirochetosis is a condition characterized by the colonization of the colonic epithelium by spirochetes, which are a group of tightly coiled bacteria. This condition can be found in both humans and animals, leading to a range of symptoms from asymptomatic carriage to mild diarrhea and abdominal discomfort. The significance of intestinal spirochetosis in clinical practice is still under investigation, as its pathogenic potential varies among individuals.
Etiology
Intestinal spirochetosis is primarily caused by two types of spirochetes: Brachyspira aalborgi and Brachyspira pilosicoli. These organisms adhere to the epithelial lining of the intestine, particularly in the colon, leading to the characteristic histopathological feature of a false brush border or a fringe on the surface of the colonic epithelium.
Epidemiology
The prevalence of intestinal spirochetosis varies globally, with higher rates reported in developing countries and among certain populations, such as men who have sex with men (MSM), HIV-positive individuals, and those with compromised immune systems. However, it can also be found in healthy individuals, making its epidemiological significance a subject of ongoing research.
Clinical Manifestations
Many individuals with intestinal spirochetosis are asymptomatic. When symptoms do occur, they can range from mild to moderate and include:
- Diarrhea
- Abdominal pain
- Nausea
- Anorexia
- Weight loss
In severe cases, rectal bleeding and mucosal ulceration have been reported, although these are less common.
Diagnosis
Diagnosis of intestinal spirochetosis is primarily made through histological examination of colonic biopsy specimens obtained during colonoscopy. The presence of a basophilic fringe on the apical surface of the colonic epithelium, visible with light microscopy, is indicative of the condition. Special staining techniques, such as silver staining, can enhance the visualization of spirochetes. Additionally, PCR and culture methods can be used for the identification of specific spirochete species.
Treatment
The need for treatment in intestinal spirochetosis is determined on a case-by-case basis, depending on the severity of symptoms and the presence of any underlying conditions. When treatment is deemed necessary, antibiotics such as metronidazole or macrolides (e.g., erythromycin) have been used with varying degrees of success. It is important to monitor for resolution of symptoms and, in some cases, repeat colonoscopy to confirm the eradication of spirochetes.
Prognosis
The prognosis for individuals with intestinal spirochetosis is generally good, especially for those who are asymptomatic or who have mild symptoms. With appropriate treatment, symptomatic patients usually experience resolution of symptoms. However, recurrence can occur, necessitating further treatment.
Prevention
Preventive measures for intestinal spirochetosis are not well established due to the incomplete understanding of its transmission and pathogenesis. General recommendations include practicing good hygiene and safe sex, as well as taking precautions when traveling to areas with high prevalence rates.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD